当前位置: 首页 > 详情页

Treatment of patients with aortic disease during pregnancy and after delivery

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiac Surg, 2 Anzhen St, Beijing 100029, Peoples R China; [2]Beijing Inst Heart Lung & Blood Vessel Dis, Beijing, Peoples R China; [3]Beijing Lab Cardiovasc Precis Med, Beijing, Peoples R China; [4]Beijing Aort Dis Ctr, Cardiovasc Surg Ctr, Beijing, Peoples R China; [5]Beijing Engn Res Ctr Vasc Prostheses, Beijing, Peoples R China; [6]2 Anzhen St, Beijing 100029, Peoples R China
出处:
ISSN:

关键词: Pregnant patient aortic disease pregnancy delivery treatment

摘要:
Objective This study aimed to review treatment of patients with aortic disease during pregnancy and after delivery in Beijing Anzhen Hospital. Methods A retrospective study was conducted using data from 12 patients with aortic disease during pregnancy and after delivery in our institution from May 2005 to December 2014. Patients were provided different treatments based on the type of aortic disease and clinical characteristics. Results The mean age was 29.834.17 years, mean height was 171.7 +/- 8.22cm, mean weight was 68.55 +/- 10.62kg, and mean body mass index was 23.18 +/- 2.93kg/m(2). Two patients with Stanford type A aortic dissection died of renal failure after surgery. All of the other patients were discharged. Six foetuses survived. One patient continued her pregnancy after an aortic operation. The gestational age of the remaining five patients was less than 28 weeks at the time of the operation and all foetuses of these five patients died. Conclusions A suitable treatment strategy for aortic disease during pregnancy and after delivery should be chosen based on an individual's comprehensive clinical condition. Foetal management should be chosen based on gestational age and severity of aortic disease.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2016]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验 4 区 药学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验 4 区 药学
JCR分区:
出版当年[2015]版:
Q3 MEDICINE, RESEARCH & EXPERIMENTAL Q4 PHARMACOLOGY & PHARMACY
最新[2024]版:
Q3 MEDICINE, RESEARCH & EXPERIMENTAL Q4 PHARMACOLOGY & PHARMACY

影响因子: 最新[2024版] 最新五年平均 出版当年[2015版] 出版当年五年平均 出版前一年[2014版] 出版后一年[2016版]

第一作者:
第一作者机构: [1]Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiac Surg, 2 Anzhen St, Beijing 100029, Peoples R China; [2]Beijing Inst Heart Lung & Blood Vessel Dis, Beijing, Peoples R China; [3]Beijing Lab Cardiovasc Precis Med, Beijing, Peoples R China; [4]Beijing Aort Dis Ctr, Cardiovasc Surg Ctr, Beijing, Peoples R China; [5]Beijing Engn Res Ctr Vasc Prostheses, Beijing, Peoples R China;
通讯作者:
通讯机构: [1]Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiac Surg, 2 Anzhen St, Beijing 100029, Peoples R China; [2]Beijing Inst Heart Lung & Blood Vessel Dis, Beijing, Peoples R China; [3]Beijing Lab Cardiovasc Precis Med, Beijing, Peoples R China; [4]Beijing Aort Dis Ctr, Cardiovasc Surg Ctr, Beijing, Peoples R China; [5]Beijing Engn Res Ctr Vasc Prostheses, Beijing, Peoples R China; [6]2 Anzhen St, Beijing 100029, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:18307 今日访问量:0 总访问量:1007 更新日期:2025-11-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院